• Explore /
  • Poster
  • / Maintenance therapy with bevacizumab with or without erlotinib in metastatic colorectal cancer (mCRC) according to KRAS: Results of the GERCOR DREAM phase III trial.

Maintenance therapy with bevacizumab with or without erlotinib in metastatic colorectal cancer (mCRC) according to KRAS: Results of the GERCOR DREAM phase III trial.

Abstract Poster

Authors

null

Christophe Tournigand

Hopital Henri Mondor, UPEC, Creteil, France

Christophe Tournigand , Benoist Chibaudel , Benoit Samson , Werner Scheithauer , Gérard Lledo , Frederic Viret , Thierry André , Jean François Ramée , Nicole Tubiana-Mathieu , Jérôme Dauba , Olivier Dupuis , Yves Rinaldi , May Mabro , Nathalie Aucoin , Ahmed Khalil , Jean Latreille , Christophe Louvet , David Brusquant , Franck Bonnetain , Aimery de Gramont

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

NCT00265824

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3515)

DOI

10.1200/jco.2013.31.15_suppl.3515

Abstract #

3515

Poster Bd #

7

Abstract Disclosures

Similar Posters

First Author: Amelie Anota

First Author: Benoist Chibaudel

First Author: Benoit Samson

First Author: Jorge Riera-Knorrenschild